Anteris Technologies Global Corp. Share Price
AVRAnteris Technologies Global Corp. Stock Performance
Open $6.29 | Prev. Close $6.25 | Circuit Range N/A |
Day Range $6.03 - $6.29 | Year Range $2.35 - $7.03 | Volume 4,417 |
Average Traded $6.16 |
Anteris Technologies Global Corp. Share Price Chart
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Anteris Technologies Global Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
13-Mar-26 | $6.58 | $6.19 | -5.93% |
12-Mar-26 | $6.72 | $6.58 | -1.79% |
11-Mar-26 | $6.64 | $6.70 | +5.10% |
10-Mar-26 | $6.09 | $6.38 | +7.69% |
09-Mar-26 | $6.07 | $5.92 | -4.52% |
06-Mar-26 | $6.19 | $6.20 | -2.13% |
05-Mar-26 | $6.30 | $6.33 | +0.08% |